Headlands Technologies’s Maravai LifeSciences MRVI Stock Holding History

Headlands Technologies’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.04M	Buy	+166,327	New	+$718K	0.11%	237
2026 Q1	–	Sell	-20,272	Closed	-$65.9K	–	880
2025 Q4	$65.9K	Buy	+20,272	New	+$68.2K	0.01%	643
2024 Q4	–	Sell	-37,071	Closed	-$308K	–	1448
2024 Q3	$308K	Buy	37,071 +22,136	+148%	+$191K	0.04%	424
2024 Q2	$107K	Buy	14,935 +10,053	+206%	+$86.8K	0.01%	630
2024 Q1	$42.3K	Buy	+4,882	New	+$33K	0.01%	757
2023 Q3	–	Sell	-991	Closed	-$12.3K	–	1100
2023 Q2	$12.3K	Buy	+991	New	+$13.4K	﹤0.01%	609

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.91B AUM 14.64% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

1WCM

12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

OAM

Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Headlands Technologies's MRVI Position: Q2 2026 in Review

Headlands Technologies opened a new position in Maravai LifeSciences (MRVI) in Q2 2026: 166,327 shares worth $1.04M. The stake represents 0.11% of the portfolio and ranks #237 among its holdings. This is a return to the name: Headlands Technologies previously reported a position in MRVI as recently as Q4 2025.

Headlands Technologies first reported a position in MRVI in Q2 2023 and has held it in 6 quarters since. 178 funds tracked by Wall St. Rank hold MRVI as of Q2 2026.

Headlands Technologies held 166,327 shares of Maravai LifeSciences worth $1.04M as of Q2 2026.
Maravai LifeSciences was a new Headlands Technologies position in Q2 2026.
Maravai LifeSciences made up 0.11% of Headlands Technologies's portfolio in Q2 2026, its #237 holding.
Headlands Technologies first reported a position in Maravai LifeSciences in Q2 2023 and has held it in 6 quarters since.
178 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2026.

Based on Headlands Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.